Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Hirofumi Tokuoka, Makoto Nishihara, Shinji Fujikoshi, Aki Yoshikawa & Atsushi Kuga. (2017) Predicting treatment outcomes of major depressive disorder by early improvement in painful physical symptoms: a pooled analysis of double-blind, placebo-controlled trials of duloxetine. Neuropsychiatric Disease and Treatment 13, pages 2457-2467.
Read now
Read now
Eiji Harada, Yoichi Satoi, Atsushi Kuga, Hirofumi Tokuoka, Toshiaki Kikuchi, Koichiro Watanabe, Levent Alev & Masaru Mimura. (2017) Associations among depression severity, painful physical symptoms, and social and occupational functioning impairment in patients with major depressive disorder: a 3-month, prospective, observational study. Neuropsychiatric Disease and Treatment 13, pages 2437-2445.
Read now
Read now
Atsushi Kuga, Toshinaga Tsuji, Shinji Hayashi, Mako Matsubara, Shinji Fujikoshi, Hirofumi Tokuoka, Aki Yoshikawa, Rodrigo Escobar, Kazuhide Tanaka & Takaharu Azekawa. (2017) An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis. Neuropsychiatric Disease and Treatment 13, pages 2105-2114.
Read now
Read now
Roy Dekel, Douglas A Drossman & Ami D Sperber. (2013) The use of psychotropic drugs in irritable bowel syndrome. Expert Opinion on Investigational Drugs 22:3, pages 329-339.
Read now
Read now
Articles from other publishers (20)
Pratap Chokka, Ash Bender, Stefan Brennan, Ghalib Ahmed, Marc Corbière, David J. A. Dozois, Jeff Habert, John Harrison, Martin A. Katzman, Roger S. McIntyre, Yang S. Liu, Karen Nieuwenhuijsen & Carolyn S. Dewa. (2023) Practical pathway for the management of depression in the workplace: a Canadian perspective. Frontiers in Psychiatry 14.
Crossref
Crossref
Stefanie Kremer, Teresa Wiesinger, Tom Bschor & Christopher Baethge. (2023) Antidepressants and Social Functioning in Patients with Major Depressive Disorder: Systematic Review and Meta-Analysis of Double-Blind, Placebo-Controlled RCTs. Psychotherapy and Psychosomatics 92:5, pages 304-314.
Crossref
Crossref
Mahesh Gajendran, Richard W. McCallum & Lucinda A. Harris. 2023. Handbook of Gastrointestinal Motility and Disorders of Gut-Brain Interactions. Handbook of Gastrointestinal Motility and Disorders of Gut-Brain Interactions
459
475
.
Yuming Tang, Jiani Song, Ying Zhu, Hefeng Chen, Weiyan Yao & Duowu Zou. (2022) Analysis of clinical characteristics of centrally mediated abdominal pain syndrome, exploration of diagnostic markers and its relationship with the efficacy of duloxetine treatment. Medicine 101:48, pages e32134.
Crossref
Crossref
Ruth Bartelli Grigolon, Alisson P. Trevizol, Fernando Gerchman, Alexander D. Bambokian, Taylor Magee, Roger S. McIntyre, Fabiano A. Gomes, Elisa Brietzke & Rodrigo B. Mansur. (2021) Is Obesity A Determinant Of Success With Pharmacological Treatment For Depression? A Systematic Review, Meta-Analysis And Meta-Regression.. Journal of Affective Disorders 287, pages 54-68.
Crossref
Crossref
Christian P. Cheung, Mathura T. Thiyagarajah, Haben Y. Abraha, Celina S. Liu, Krista L. Lanctôt, Alex J. Kiss, Mahwesh Saleem, Ari Juda, Anthony J. Levitt, Ayal Schaffer, Amy H. Cheung & Mark Sinyor. (2021) The association between placebo arm inclusion and adverse event rates in antidepressant randomized controlled trials: An examination of the Nocebo Effect. Journal of Affective Disorders 280, pages 140-147.
Crossref
Crossref
Fenghua Li, Madeeha Nasir, Baris Olten & Michael H. Bloch. (2020) Meta-analysis of placebo group dropout in adult antidepressant trials. Progress in Neuro-Psychopharmacology and Biological Psychiatry 98, pages 109777.
Crossref
Crossref
Shilpa Telang, Celeste Walton, Baris Olten & Michael H. Bloch. (2018) Meta-analysis: Second generation antidepressants and headache. Journal of Affective Disorders 236, pages 60-68.
Crossref
Crossref
Kiley Cappetta, Chad Beyer, Jessica A. Johnson & Michael H. Bloch. (2018) Meta-analysis: Risk of dry mouth with second generation antidepressants. Progress in Neuro-Psychopharmacology and Biological Psychiatry 84, pages 282-293.
Crossref
Crossref
Yena Lee, Joshua D. Rosenblat, JungGoo Lee, Nicole E. Carmona, Mehala Subramaniapillai, Margarita Shekotikhina, Rodrigo B. Mansur, Elisa Brietzke, Jae-Hon Lee, Roger C. Ho, Samantha J. Yim & Roger S. McIntyre. (2018) Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: A systematic review. Journal of Affective Disorders 227, pages 406-415.
Crossref
Crossref
Chad Beyer, Kiley Cappetta, Jessica A. Johnson & Michael H. Bloch. (2017) Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants. Depression and Anxiety 34:12, pages 1134-1146.
Crossref
Crossref
Harley W Sobin, Thomas W Heinrich & Douglas A Drossman. (2017) Central Neuromodulators for Treating Functional GI Disorders: A Primer. American Journal of Gastroenterology 112:5, pages 693-702.
Crossref
Crossref
Stefan GebhardtMonika Heinzel-GutenbrunnerUdo König. (2016) Pain Relief in Depressive Disorders. Journal of Clinical Psychopharmacology 36:6, pages 658-668.
Crossref
Crossref
Laurie Keefer, Douglas A. Drossman, Elspeth Guthrie, Magnus Simrén, Kirsten Tillisch, Kevin Olden & Peter J. Whorwell. (2016) Centrally Mediated Disorders of Gastrointestinal Pain. Gastroenterology 150:6, pages 1408-1419.
Crossref
Crossref
Vanessa C. Evans, Golnoush Alamian, Jane McLeod, Cindy Woo, Lakshmi N. Yatham & Raymond W. Lam. (2016) The Effects of Newer Antidepressants on Occupational Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. CNS Drugs 30:5, pages 405-417.
Crossref
Crossref
Jihyung Hong, Diego Novick, William Montgomery, Maria Victoria Moneta, Héctor Dueñas, Xiaomei Peng & Josep Maria Haro. (2015)
Real‐world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in
E
ast
A
sia
. Asia-Pacific Psychiatry 8:1, pages 51-59.
Crossref
Crossref
Eiji Harada, Hirofumi Tokuoka, Shinji Fujikoshi, Jumpei Funai, Madelaine M. Wohlreich, Michael H. Ossipov & Nakao Iwata. (2016) Is duloxetine's effect on painful physical symptoms in depression an indirect result of improvement of depressive symptoms? Pooled analyses of three randomized controlled trials. Pain 157:3, pages 577-584.
Crossref
Crossref
David V. Sheehan, Michele Mancini, Jianing Wang, Lovisa Berggren, Haijun Cao, Héctor José Dueñas & Li Yue. (2015) Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitors. Human Psychopharmacology: Clinical and Experimental 31:1, pages 53-63.
Crossref
Crossref
David A. Fishbain, Brandly Cole, John E. Lewis & Jinrun Gao. (2014) Does Pain Interfere with Antidepressant Depression Treatment Response and Remission in Patients with Depression and Pain? An Evidence-Based Structured Review. Pain Medicine 15:9, pages 1522-1539.
Crossref
Crossref
Michael PT Lunn, Richard AC Hughes & Philip J Wiffen. (2014) Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database of Systematic Reviews 2015:10.
Crossref
Crossref